Over the last 7 days, the Pharma industry has risen 15%, driven by gains from Curaleaf Holdings of 43%. In the same time, Cardiol Therapeutics was down 27%. In contrast, the industry has lost 36% in the last 12 months. Looking forward, earnings are forecast to grow by 51% annually.
Has the Canadian Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sun, 10 Aug 2025 | CA$13.6b | CA$11.7b | -CA$2,500,577,706.47 | 27.2x | -5.5x | 1.2x |
Tue, 08 Jul 2025 | CA$10.1b | CA$11.7b | -CA$2,537,375,713.86 | 18.9x | -4x | 0.9x |
Thu, 05 Jun 2025 | CA$9.6b | CA$11.7b | -CA$2,521,126,468.31 | 18.4x | -3.8x | 0.8x |
Sat, 03 May 2025 | CA$10.8b | CA$11.9b | -CA$2,504,613,172.59 | 20.9x | -4.3x | 0.9x |
Mon, 31 Mar 2025 | CA$10.3b | CA$12.3b | -CA$2,594,343,288.57 | 19.5x | -4x | 0.8x |
Wed, 26 Feb 2025 | CA$11.8b | CA$12.1b | -CA$2,224,950,738.88 | 22.1x | -5.3x | 1x |
Fri, 24 Jan 2025 | CA$12.2b | CA$12.1b | -CA$2,412,909,066.25 | 34.2x | -5x | 1x |
Sun, 22 Dec 2024 | CA$12.7b | CA$12.1b | -CA$2,414,708,151.37 | 21.1x | -5.3x | 1x |
Tue, 19 Nov 2024 | CA$14.9b | CA$12.0b | -CA$2,653,132,502.20 | 17.1x | -5.6x | 1.2x |
Thu, 17 Oct 2024 | CA$18.6b | CA$11.7b | -CA$2,702,419,609.24 | 17.5x | -6.9x | 1.6x |
Sat, 14 Sep 2024 | CA$18.0b | CA$11.6b | -CA$2,702,980,027.35 | 20.7x | -6.6x | 1.5x |
Mon, 12 Aug 2024 | CA$18.8b | CA$11.7b | -CA$2,772,137,137.64 | 23.6x | -6.8x | 1.6x |
Wed, 10 Jul 2024 | CA$19.1b | CA$11.7b | -CA$3,191,369,717.07 | 18.8x | -6x | 1.6x |
Fri, 07 Jun 2024 | CA$20.8b | CA$11.7b | -CA$2,743,874,058.49 | 12.9x | -7.6x | 1.8x |
Sun, 05 May 2024 | CA$24.9b | CA$11.8b | -CA$3,419,189,697.66 | 11.4x | -7.3x | 2.1x |
Tue, 02 Apr 2024 | CA$20.6b | CA$10.5b | -CA$3,537,385,853.99 | 9.1x | -5.8x | 2x |
Thu, 29 Feb 2024 | CA$21.9b | CA$12.0b | -CA$4,651,466,551.37 | 9.2x | -4.7x | 1.8x |
Sat, 27 Jan 2024 | CA$22.4b | CA$12.3b | -CA$6,749,706,536.00 | 9.6x | -3.3x | 1.8x |
Mon, 25 Dec 2023 | CA$17.0b | CA$12.2b | -CA$6,714,594,490.00 | 8.6x | -2.5x | 1.4x |
Wed, 22 Nov 2023 | CA$18.0b | CA$12.5b | -CA$6,838,470,834.00 | 7.1x | -2.6x | 1.4x |
Fri, 20 Oct 2023 | CA$17.6b | CA$12.4b | -CA$7,346,408,234.00 | 12.9x | -2.4x | 1.4x |
Sun, 17 Sep 2023 | CA$23.4b | CA$13.0b | -CA$7,894,153,313.00 | 14.8x | -3x | 1.8x |
Tue, 15 Aug 2023 | CA$13.9b | CA$13.1b | -CA$8,065,410,468.00 | 11.7x | -1.7x | 1.1x |
Thu, 13 Jul 2023 | CA$16.1b | CA$13.1b | -CA$9,497,075,855.00 | 12.6x | -1.7x | 1.2x |
Sat, 10 Jun 2023 | CA$14.8b | CA$13.2b | -CA$10,391,542,498.00 | 10.4x | -1.4x | 1.1x |
Mon, 08 May 2023 | CA$16.6b | CA$13.2b | -CA$10,199,872,771.00 | 11.1x | -1.6x | 1.3x |
Wed, 05 Apr 2023 | CA$15.5b | CA$13.4b | -CA$10,020,182,119.00 | 9.1x | -1.5x | 1.2x |
Fri, 03 Mar 2023 | CA$19.5b | CA$13.7b | -CA$10,342,302,895.00 | 9.9x | -1.9x | 1.4x |
Sun, 29 Jan 2023 | CA$19.4b | CA$13.5b | -CA$10,086,714,036.00 | 14.3x | -1.9x | 1.4x |
Tue, 27 Dec 2022 | CA$20.1b | CA$13.6b | -CA$10,141,873,707.00 | 13.4x | -2x | 1.5x |
Thu, 24 Nov 2022 | CA$30.1b | CA$13.4b | -CA$10,220,414,833.00 | 10.5x | -2.9x | 2.2x |
Sat, 22 Oct 2022 | CA$27.9b | CA$13.5b | -CA$9,412,446,867.00 | 11.1x | -3x | 2.1x |
Mon, 19 Sep 2022 | CA$28.4b | CA$13.1b | -CA$8,843,772,737.00 | 13.7x | -3.2x | 2.2x |
Wed, 17 Aug 2022 | CA$30.5b | CA$12.8b | -CA$8,787,446,043.00 | 13.4x | -3.5x | 2.4x |
-3.5x
Which industries have driven the changes within the Canadian Healthcare industry?
CA Market | 1.30% | |
Healthcare | 8.31% | |
Pharma | 14.68% | |
Pharma | 14.68% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
CURA Curaleaf Holdings | CA$2.80 | 42.9% +CA$642.1m | -38.1% | PS1.2x | |
TRUL Trulieve Cannabis | CA$7.92 | 22.0% +CA$273.3m | -41.4% | PS0.9x | |
CRON Cronos Group | CA$3.18 | 18.2% +CA$181.0m | 5.0% | PE47.9x | |
VRNO Verano Holdings | CA$1.30 | 36.8% +CA$126.9m | -74.0% | PS0.4x | |
GTII Green Thumb Industries | CA$9.83 | 5.5% +CA$118.1m | -36.4% | PE57.2x |